title: [PROLOGO: efalizumab].
authors.affiliation: Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
authors.forename: F
authors.initials: F
authors.lastname: Vanaclocha Sebastián
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products / Q000627:therapeutic use*; D040881:CD11a Antigen / Q000276:immunology; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D011565:Psoriasis / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D040881:CD11a Antigen; D003879:Dermatologic Agents; C472181:efalizumab